Call for proposals to support the development of a medicine pricing, reimbursement and access tracker through the EURIPID database

This EU funding opportunity is part of the EU4Health Programme and falls under the EU4H SANTE Action Grants 2025 call. It aims to support the development of a medicine pricing, reimbursement, and access tracker through the EURIPID database. The planned opening date for submissions is September 23, 2025, with a deadline of January 6, 2026, at 17:00 Brussels time. The total budget for this initiative is €750,000.

The primary goal of this action is to enhance understanding of patient access to medicines within the European Union, improve the database quality, and expand the EURIPID membership to include all Member States. The initiative seeks to foster mutual learning among national authorities to improve pricing and reimbursement decisions, ultimately enhancing the accessibility, availability, and affordability of medicines, particularly cancer treatments.

Key deliverables include developing a pricing and reimbursement tracker that provides national information on early access schemes, tracking applications and decisions, and conditions related to pricing and reimbursement. Additionally, the project involves creating access dashboards based on OECD indicators, annual trend analysis reports, and automating data sharing solutions. The initiative will also focus on enhancing interoperability with existing databases within the European Health Data Space.

Eligible applicants are expected to include organizations active in the healthcare sector, such as public organizations, private entities, research institutions, and universities, though specific criteria will be detailed in the call document.

The call is structured as a single-stage submission process, with the budget for individual projects ranging from €600,000 to €20 million across various topics within the call. Important details regarding admissibility, eligibility, and evaluation criteria will be found in the call document. To apply, participants must use the standard application form provided in the submission system, and the call emphasizes the need for detailed budgeting and project planning to ensure alignment with the broader objectives of the EU4Health Programme, including promoting the cost-effective use of medicines.

This EU funding opportunity is part of the EU4Health Programme (EU4H) and falls under the EU4H SANTE Action Grants 2025 (EU4H-2026-SANTE-PJ) call. It is an EU4H Project Grant (EU4H-PJG) with a budget-based EU4H Action Grant (EU4H-AG) mechanism. The deadline model is single-stage. The planned opening date is 23 September 2025, and the deadline is 6 January 2026 at 17:00:00 Brussels time.

The call aims to support the development of a medicine pricing, reimbursement, and access tracker through the EURIPID database.

The expected impact of this action is twofold. In the short term, it will provide EURIPID members with a better overview of access, pricing and reimbursement (P&R) measures, and decisions across the Member States. In the longer term, it is expected to foster mutual learning between national authorities and assist Member States in making improved pricing and reimbursement decisions, ultimately enhancing access, availability, and affordability of medicines. This initiative aligns with the recommendations of the Draghi Report on European competitiveness and the priority of ensuring affordable medicine supply, as emphasized in Commission President von der Leyen's mission letter to the Commissioner for Health and Animal Welfare. The pricing and reimbursement tracker and access dashboard will enable better monitoring of patient access to medicines across the Union, including cancer treatments, and will serve as a baseline to measure the impact of proposed pharmaceutical reforms.

The objectives of this call are to:

a) Measure and increase understanding of patient access to medicines in the Union.

b) Increase the quality of the database, ensuring timely and correct data delivery.

c) Expand the scope of EURIPID members to include all Member States and broaden the data coverage.

d) Leverage the usefulness of the data beyond external reference pricing purposes.

The scope of this action involves developing the following through the EURIPID database:

a) A pricing and reimbursement (P&R) tracker, including national information on early access schemes, P&R applications (status and decision), and P&R criteria or conditions (general and product-specific).

b) Access dashboards, building on OECD indicators, focusing on availability (e.g., coverage status, time-to-reimbursement), affordability (e.g., cost of treatment), and accessibility (e.g., consumption/uptake).

c) An annual trend analysis report on access to medicines in the Union.

d) Solutions to facilitate data sharing with EURIPID, such as automatization using application programming interface (API) and machine-to-machine interaction with each Member State.

e) Reinforced interoperability of EURIPID with other existing databases (e.g., the European Shortages Medicine Platform, Substance, Product, Organisation and Referential master data, Product Management Service, etc.) and integrating data assets in the European Health Data Space.

The conditions for this call include:

1. Admissibility Conditions: The proposal page limit and layout are described in section 5 of the call document and Part B of the Application Form available in the Submission System.

2. Eligible Countries are described in section 6 of the call document.

3. Other Eligible Conditions are described in section 6 of the call document.

4. Financial and operational capacity and exclusion are described in section 7 of the call document.

5a. Evaluation and award: Submission and evaluation processes are described in section 8 of the call document and the Online Manual.

5b. Evaluation and award: Award criteria, scoring, and thresholds are described in section 9 of the call document.

5c. Evaluation and award: The indicative timeline for evaluation and grant agreement is described in section 4 of the call document.

6. Legal and financial set-up of the grants are described in section 10 of the call document.

The call document and annexes include:

Call document

Application form templates:

Standard application form (EU4H) available in the Submission System

Detailed budget table (EU4H)

Model Grant Agreements (MGA):

EU4H MGA

Additional documents:

EU4H Work Programme

EU4H Regulation 2021/522

EU Financial Regulation 2024/2509

Rules for Legal Entity Validation, LEAR Appointment, and Financial Capacity Assessment

EU Grants AGA Annotated Model Grant Agreement

Funding & Tenders Portal Online Manual

Funding & Tenders Portal Terms and Conditions

Funding & Tenders Portal Privacy Statement

The budget overview for the year 2025 includes the following topics:

EU4H-2026-SANTE-PJ-01 EU4H-PJG EU4H Project Grants with a budget of 3,000,000 EUR

EU4H-2026-SANTE-PJ-02 EU4H-PJG EU4H Project Grants with a budget of 7,440,000 EUR

EU4H-2026-SANTE-PJ-03 EU4H-PJG EU4H Project Grants with a budget of 7,440,000 EUR

EU4H-2026-SANTE-PJ-04 EU4H-PJG EU4H Project Grants with a budget of 20,000,000 EUR

EU4H-2026-SANTE-PJ-05 EU4H-PJG EU4H Project Grants with a budget of 2,000,000 EUR

EU4H-2026-SANTE-PJ-06 EU4H-PJG EU4H Project Grants with a budget of 750,000 EUR

EU4H-2026-SANTE-PJ-07 EU4H-PJG EU4H Project Grants with a budget of 1,200,000 EUR

EU4H-2026-SANTE-PJ-08 EU4H-PJG EU4H Project Grants with a budget of 14,386,810 EUR

EU4H-2026-SANTE-PJ-09 EU4H-PJG EU4H Project Grants with a budget of 600,000 EUR

All topics follow a single-stage submission process, with the opening date planned for 2025-09-23 and the deadline on 2026-01-06.

There are partner search announcements available for collaboration on this topic. LEARs, Account Administrators, and self-registrants can publish partner requests on the Funding & Tenders Portal.

The submission system is planned to open on the date stated in the topic header.

For support, applicants are advised to read all provisions carefully before preparing their application. For call-related help, contact HaDEA-HP-CALLS@ec.europa.eu. For IT-related issues, contact the IT Helpdesk. The Online Manual provides a step-by-step guide through the Portal processes.

In summary, this funding opportunity aims to enhance the EURIPID database to improve the monitoring of medicine pricing, reimbursement, and patient access across the European Union. It seeks to create tools and reports that will support better decision-making by national authorities and ultimately improve the availability, affordability, and accessibility of medicines, including cancer treatments. The call encourages projects that can develop a pricing and reimbursement tracker, access dashboards, and solutions for data sharing and interoperability with other relevant databases. The call is structured as a single-stage submission process with a planned opening date in September 2025 and a deadline in January 2026.

Eligible Applicant Types: The eligible applicant types are not explicitly stated in the provided text. However, given the nature of the EU4Health Programme and the objectives of the call, it can be inferred that eligible applicants may include public organizations, private organizations, research institutions, universities, and other relevant entities active in the healthcare sector within the EU. Further details would be available in section 6 of the call document.

Funding Type: The funding type is a grant, specifically an EU4H Project Grant (EU4H-PJG) under the EU4Health Programme. The type of Model Grant Agreement (MGA) is EU4H Action Grant Budget-Based [EU4H-AG].

Consortium Requirement: The text does not explicitly state whether a single applicant or a consortium is required. Further details would be available in section 6 of the call document.

Beneficiary Scope (Geographic Eligibility): The geographic eligibility appears to be focused on EU Member States, as the project aims to improve access to medicines across the Union and involves EURIPID members, which include all the Member States. Further details would be available in section 6 of the call document.

Target Sector: The target sector is health, specifically focusing on pharmaceuticals, healthcare, and related data management and interoperability. The program targets improving access, availability, and affordability of medicines, including cancer treatments, within the European Union.

Mentioned Countries: No specific countries are mentioned, but the opportunity is focused on the European Union and its Member States.

Project Stage: The project stage appears to be focused on development and implementation, specifically developing a pricing and reimbursement tracker and access dashboard using the EURIPID database. This suggests a move from research to practical application and data-driven solutions.

Funding Amount: The funding amounts vary depending on the specific project within the call. The budget overview lists individual project grants ranging from EUR 600,000 to EUR 20,000,000.
EU4H-2026-SANTE-PJ-01: EUR 3,000,000
EU4H-2026-SANTE-PJ-02: EUR 7,440,000
EU4H-2026-SANTE-PJ-03: EUR 7,440,000
EU4H-2026-SANTE-PJ-04: EUR 20,000,000
EU4H-2026-SANTE-PJ-05: EUR 2,000,000
EU4H-2026-SANTE-PJ-06: EUR 750,000
EU4H-2026-SANTE-PJ-07: EUR 1,200,000
EU4H-2026-SANTE-PJ-08: EUR 14,386,810
EU4H-2026-SANTE-PJ-09: EUR 600,000

Application Type: The application type is an open call, with a single-stage submission process. The submission system is planned to be opened on September 23, 2025, and the deadline for submission is January 6, 2026, at 17:00:00 Brussels time.

Nature of Support: The beneficiaries will receive money in the form of grants to support the development and implementation of the proposed projects.

Application Stages: The application process is a single-stage process.

Success Rates: The success rates are not mentioned in the provided text.

Co-funding Requirement: The text does not explicitly state whether co-funding is required.

Summary:
This opportunity is a call for proposals under the EU4Health Programme (EU4H), specifically targeting EU4H Project Grants (EU4H-PJG). The call aims to support the development of a medicine pricing, reimbursement, and access tracker through the EURIPID database. The primary goal is to enhance the understanding of patient access to medicines across the European Union, improve the quality and scope of the EURIPID database, and facilitate mutual learning among national authorities to improve pricing and reimbursement decisions.

The scope of the action involves developing a pricing and reimbursement tracker, access dashboards, an annual trend analysis report, solutions for data sharing, and reinforced interoperability with other existing databases, including the European Health Data Space. The expected impact includes providing EURIPID members with a better overview of access, pricing, and reimbursement measures, and supporting Member States in making better decisions to improve access, availability, and affordability of medicines, including cancer treatments.

The call is structured as a single-stage submission process, with the planned opening date for submissions on September 23, 2025, and a deadline of January 6, 2026. The funding amounts vary by project, ranging from EUR 600,000 to EUR 20,000,000. Eligible applicants are expected to be organizations active in the healthcare sector within the EU, though specific eligibility criteria are detailed in section 6 of the call document.

To apply, applicants must use the standard application form (EU4H) available in the Submission System and provide a detailed budget table. Additional documents such as the EU4H Work Programme, EU4H Regulation 2021/522, and EU Financial Regulation 2024/2509 are also relevant. The call emphasizes the importance of interoperability and data sharing to support the broader goals of the European Health Data Space.